Oral glucose tolerance tests (OGTT) with glucose, insulin and c-peptide sampling can be informative to define the insulin-response phenotype in healthy individuals but may not be advisable in the context of sustained dietary KMT and active cancer [195, 301]. The gene discussed is INS; the disease is cancer.